An observational study in Sjogren's Syndrome, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Completed. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-07-27.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational
Patients with pSS seen in the Division of Rheumatology, the second affiliated hospital of Zhejiang University, School of Medicine (SAHZU) during January 2016 to July 2018, were retrospectively reviewed. Characteristics were analyzed.
Patients with pSS were retrospectively reviewed, and pSS-ILD and pSS non-ILD were identified. Clinical data, laboratory parameters, pulmonary high-resolution CT (HRCT), and pulmonary function tests (PFTs) were collected. pSS-ILD patients were further categorized into subgroups according to HRCT patterns or PFTs.
371 studies on the registry are indexed under Sjogren's Syndrome; 104 are open to participants now.
This study's enrollment of 170 is above the median of 114 across 113 observational studies indexed under Sjogren's Syndrome.
Browse Sjogren's Syndrome studies →Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Eighty-five patients with pSS-ILD were identified, and 85 patients with pSS non-ILD were used for comparison. The average age at disease onset and median disease duration in patients with pSS-ILD were greater when compared with pSS non-ILD patients. There was no difference regarding presenting symptoms at disease onset between pSS-ILD and pSS non-ILD patients.
Exclusion Criteria:
diagnosis of pSS-ILD was based on abnormal HRCT and PFTs
Other: No intervention
pSS patients after exclusion of pSS-ILD and concomitant pulmonary diseases were considered as pSS non-ILD
Other: No intervention
No intervention
observational study, data analysis to identify the risk factors of pSS-ILD
ILD progressed in 6 months from baseline
Time frame: 6 months from baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University